Nuvectis Pharma Inc (NVCT) — Cash Flow Reinvestment Rate
Latest as of December 2020:
0.00x
Nuvectis Pharma Inc (NVCT) has a Cash Flow Reinvestment Rate of 0.00x as of December 2020, reinvesting $0.00 (capex $0.00 ) from operating cash flow of $24.00K. See debt-free asset ratio of Nuvectis Pharma Inc to measure how much of total assets are equity-financed.
Reinvestment Rate
0.00x
(Capex + Investments) / Operating CF
Total Reinvested
$0.00
Capex + Investments
Operating Cash Flow
$24.00K
USD
Capital Expenditures
$0.00
USD
Nuvectis Pharma Inc Cash Flow Reinvestment Rate (2020–2020)
Historical reinvestment intensity for Nuvectis Pharma Inc across 1 annual periods. Also explore NVCT total asset value for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Nuvectis Pharma Inc (2020–2020)
Year-by-year capital reinvestment analysis for Nuvectis Pharma Inc. For live market cap and broader valuation context, see Nuvectis Pharma Inc market capitalisation.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2020 | 0.00x | $0.00 | $24.00K | $0.00 | — |
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow